Engineered endosymbionts that alter mammalian cell surface marker, cytokine and chemokine expression

Abstract

The establishment of non-pathogenic engineered endosymbionts through B. subtilis is presented, with the aim of delivering mammalian transcription factors to the host cell for therapeutics and research.